(Q46862606)

25 December 2017

title

Adherence to HAART: processes explaining adherence behavior in acceptors and non-acceptors (English)

1 reference

25 December 2017

author name string

Sigrid C J M Vervoort

1

1 reference

25 December 2017

Mieke H F Grypdonck

2

1 reference

25 December 2017

Annelies de Grauwe

3

1 reference

25 December 2017

Andy I M Hoepelman

4

1 reference

25 December 2017

Jan C C Borleffs

5

1 reference

25 December 2017

publication date

1 April 2009

1 reference

25 December 2017

published in

AIDS Care

1 reference

25 December 2017

volume

21

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

431-438

1 reference

25 December 2017

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

High levels of adherence do not prevent accumulation of HIV drug resistance mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

HIV-1 drug resistance in newly infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

A method of analysing interview transcripts in qualitative research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

Implementation intentions: Strong effects of simple plans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

The use of implementation intentions and the decision balance sheet in promoting exercise behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

How qualitative methods contribute to understanding combination antiretroviral therapy adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

Adherence in antiretroviral therapy: a review of qualitative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

The role of theory in HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120802290381

10.1080/09540120802290381

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

19266408

1 reference

25 December 2017